Nomad Foods: King of the Freezer Ailse

Nomad is the runaway leader in European frozen food, home to Birds Eye, iglo, Findus, Goodfella's and a string of local champions. It holds the top spot in 13 of the 15 countries it operates in, and across its 25 most important product battles its brands command more than twice the combined share of all other branded rivals. Scale on this level buys real advantages: prime freezer space, close ties with the big supermarkets, the budget to keep advertising, and enough pricing power to pass on cost increases. In a category shoppers return to in any economy, that leadership is hard for challengers or own-label to dislodge.

Frozen food is a steady, cash-generative business, and even in a soft 2025 Nomad turned a healthy share of its profits into spare cash. It produced around 182 million euro of adjusted free cash flow that year and aims to convert 90% or more of profit into cash going forward. The cash funds a dividend yielding in the mid-to-high single digits alongside a steady buyback, with 195.6 million euro of shares repurchased in 2025 and more bought since. The puzzle is the price. Despite that cash generation, the shares trade on a lower earnings multiple than many food-industry peers, so investors are picking up the income and cash returns at a discount, and every buyback retires stock cheaply and lifts the value of what remains.

A refreshed management team is now in place and moving quickly. Dominic Brisby became chief executive in January 2026, bringing experience from Flora Food Group and a long career at Imperial Brands, and has added a new marketing chief and fresh regional heads. The centrepiece is a 200 million euro efficiency programme to 2028, led by a major overhaul of how the group buys ingredients and packaging, with further savings in factories, logistics and overheads. Part of the benefit is being reinvested into brands and products, and a fuller growth plan is due at an investor day later in 2026. Tellingly, the CEO and colleagues have been buying shares with their own money.

• August half-year results: Nomad has already flagged second-quarter profit ahead of expectations. A solid print would show the sales decline is easing.
  

• Completing the debt refinancing: The new 800 million euro bond removes the looming 2028 maturity and clarifies future interest costs.

• Autumn investor day: Management lays out its full growth strategy, the market's first proper look at the new team's plan.
  

• Efficiency savings showing up: Visible progress on the 200 million euro cost programme feeding through to margins and cash.

• A return to volume growth: Category recovery and new protein and chicken launches turning brand strength into steady sales growth.
  

• Re-rating as the plan delivers: A low multiple and high yield leave room to re-rate if profits and cash returns hold up.

Nomad has been selling less product. Organic revenue fell across 2025 and dropped again in early 2026, with first-quarter volumes down more than 4%, though some of that was a deliberate clean-up of inefficient order patterns. Shoppers remain price-conscious, and cheaper supermarket own-label ranges compete directly with Nomad's brands on the same shelves. If volumes do not stabilise and the category's recovery stalls, the company's growth ambitions rest heavily on higher prices and better product mix rather than selling more units.

The group carries a large amount of borrowing, close to 2 billion euro net of cash, a legacy of the debt-funded deals that built it. In mid-2026 it moved to refinance, raising 800 million euro of new notes to replace debt maturing in 2028. Management expects this to lift interest costs, which it plans to offset over time by paying down net debt. Higher interest payments reduce the cash left for dividends, buybacks and investment, and if profits keep falling the debt looks larger relative to earnings. It is manageable for now, but it lowers the margin for error.

Much of the optimism rests on plans that have not yet played out. The new chief executive has only been in post since January 2026, the 200 million euro savings programme runs to 2028, and the broader growth strategy will not be spelled out until an investor day later this year. Cost programmes can slip, savings can be competed away on price, and new-product pushes do not always land. The medium-term profit growth target is modest, so the market will want clear evidence that the plan is working before rewarding the shares.